H.R. 10394, Medicare Advantage Claims Protection. Quorum's AI analysis reads it as a net benefit — and names who gains.
H.R. 10394 · Net good
What it does
This bill prohibits Medicare Advantage plans from denying coverage or reopening claims after they have already approved an item or service through prior authorization or concurrent approval. Once an MA plan approves care (either before or during treatment), it cannot later deny that same care as medically unnecessary, reopen the approval without good cause or fraud evidence, or reduce payment by recoding the claim—protecting patients from surprise denials after care is delivered.
The analysis names Medicare Advantage enrollees (reduced risk of post-service claim denials) — and 1 more group — among the beneficiaries.
The trade-off
MA plans may respond by tightening prior authorization criteria upfront, making initial approvals harder to obtain—shifting the denial burden earlier in the care pathway rather than eliminating it.
Transparency scores 85%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Greg Landsman. Cosponsored by Mariannette Miller-Meeks and Robert Onder.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.